This is a rare condition where tiny cells called histiocytes grow too much in the sinuses, which are the hollow spaces in your nose. It often causes large, swollen lymph nodes, especially in the neck. It's usually not dangerous, but it can cause breathing problems or infections.
Every report comes from a Lived member, sent anonymously.
Have you tried Prednisone for Rosai-Dorfman Disease?
Rosai-Dorfman disease (RDD), also called Rosai-Dorfman-Destombes disease or sinus histiocytosis with massive lymphadenopathy, is a rare disorder in which histiocytes, a type of immune cell that normally helps clear debris and infection, build up in tissues and form swellings or masses. Its classic form causes very large, painless lymph nodes on both sides of the neck, sometimes with fevers, night sweats or weight loss. RDD does not stay in the lymph nodes for everyone. In roughly four in ten cases it affects other parts of the body, such as the skin, the nose and sinuses, the eye socket, bone, the brain or spinal cord, the kidneys or the lungs. Where it appears largely determines what symptoms it causes and how serious it is. It is most often found in children and young adults, though it can occur at any age. RDD belongs to a family of conditions called histiocytoses and is distinct from Langerhans cell histiocytosis, a better-known relative.
The cause of RDD is not fully understood, and it may not be the same in every person. For a long time it was regarded as an unusual immune reaction. More recently, some people's affected tissue has been found to carry gene changes that switch on a cell-growth pathway (the MAPK pathway), and RDD is now classified as a type of blood-cell neoplasm, meaning an abnormal growth of cells. These gene changes arise in the affected cells during life and are not inherited. A small number of families carry inherited changes in a gene called SLC29A3, which can cause RDD alongside other features such as hearing loss. About one in ten people with RDD also have an autoimmune condition, such as lupus or juvenile arthritis, and RDD-like changes sometimes appear alongside lymphoma. Viral infections have been suspected as triggers, but no clear link has been proven. RDD is more common in males and in people of African descent.
RDD is diagnosed with a biopsy, in which a sample of an enlarged lymph node or other affected tissue is removed and examined under a microscope. The pathologist looks for the characteristic large histiocytes and uses special stains to confirm their type. Because RDD is rare and can resemble other conditions, the sample is ideally reviewed by a pathologist familiar with it. Imaging such as CT or MRI can show where swellings are but cannot tell RDD apart from other causes on its own. A biopsy finding is only part of the answer. Large lymph nodes with fever and weight loss can also be caused by lymphoma, infections and other diseases, so the assessment includes ruling these out. Once RDD is confirmed, doctors map where it is in the body, usually with scans of the neck, chest, abdomen and pelvis, and sometimes a PET scan (a scan that highlights metabolically active tissue). In children, ultrasound and MRI are often used to limit radiation. Blood tests check blood counts, inflammation, kidney and liver function and immune markers, and look for associated autoimmune disease or infections such as HIV and hepatitis. MRI of the brain, spine or eye socket is added when symptoms point there.
There is no single standard treatment for RDD, and the plan depends on where the disease is, whether it is causing problems and how it behaves over time. Many people need no treatment at first. For uncomplicated lymph node swelling or skin lesions that are not causing symptoms, careful monitoring is reasonable, because an estimated 20% to 50% of these cases settle down on their own. When a single area is affected, surgery to remove it can be curative, and surgical removal is the most effective treatment for RDD of the skin. Surgery is also used to relieve pressure when a mass threatens the airway, presses on the spinal cord or damages an organ. Corticosteroids such as prednisone or dexamethasone often shrink swollen nodes and ease symptoms, but responses vary, the disease can return when they are stopped, and disease outside the lymph nodes often does not stay controlled with steroids alone. For disease that is widespread, keeps coming back or threatens organs, specialists draw on low-dose chemotherapy drugs such as methotrexate, immune-modifying medicines, rituximab (an antibody that targets certain immune cells) or radiation to a specific area. Some of the stronger chemotherapy options suppress the bone marrow and raise the risk of infection, so they are reserved for cases where the benefit justifies it. Testing the biopsy for gene changes can open the door to targeted drugs. Cobimetinib (Cotellic), a MEK inhibitor that blocks the overactive growth pathway, is FDA-approved for adults with histiocytic neoplasms, a group that includes RDD, although the trial behind that approval included only a few people with RDD. It requires regular monitoring, including eye and heart checks. Because the evidence for most RDD treatments comes from small case series rather than large trials, care at a center experienced with histiocytic disorders can help.
For most people with RDD confined to the lymph nodes or skin, the outlook is good. The disease is often self-limited, and swellings may shrink with or without treatment. Others have a more unpredictable course, with periods of remission and flare-ups that can continue for years. The outlook is less favorable when RDD involves several areas outside the lymph nodes, particularly the kidneys, liver or lower airways and lungs. Disease in the brain or spinal cord can be serious, though many people do well after surgery when the lesion can be removed. Daily life depends largely on which sites are involved: some people notice little beyond a visible neck swelling, while others manage symptoms such as nasal blockage, bone pain or effects on vision. Follow-up continues even when no treatment is needed, to make sure the disease is not spreading or causing new problems. When treatment starts, the first check of how well it is working usually comes within about four months. If the disease is stable or in remission, visits and scans can often be spaced out to every six to twelve months. Because flare-ups can occur after a long quiet period, it helps to keep the care team informed about new swellings or symptoms.
See a doctor if you have lymph nodes that stay enlarged for more than a few weeks, especially with fevers, night sweats or unexplained weight loss, or if you have new lumps in the skin or elsewhere that are not going away. If you already have RDD, tell your care team about new swellings, bone pain, persistent cough, blood in the urine or nasal blockage so they can check whether the disease has spread. Contact your care team the same day for new headaches, weakness or numbness in a limb, trouble walking, new back pain, changes in vision or a bulging eye, or breathing or swallowing that is getting harder, because these can mean a mass is pressing on the nerves, spinal cord or airway. A seizure or severe difficulty breathing needs emergency care right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Rosai-Dorfman Disease is like, what's helped you, or ask the community a question.